Modifications and Degradation of High Density Lipoproteins

  • A. Angel
  • B. Fong
Part of the Advances in Experimetal Medicine and Biology book series (AEMB, volume 201)


Plasma high density lipoproteins (HDL) attract wide interest because of their putative antiatherogenic role in man (1). It has been repeatedly demonstrated that the plasma concentration of HDL cholesterol correlates inversely with coronary disease risk and this is true for both men and women (2). This protective effect of HDL is independent of total plasma cholesterol levels and is thus viewed as a risk predictor independent of all other lipoprotein classes. Reduced plasma HDL cholesterol levels are associated with a large number of clinical states and the list continues to grow. In Table 1, both genetic and acquired diseases where HDL cholesterol are frequently reduced with increased risk for coronary heart disease is shown. Tempting as it is to attribute causality to the HDL particle per se, the precise mechanism or mechanisms responsible for the protection associated with this lipoprotein has not been determined. It is evident that until all the relevant functional properties of HDL as it circulates in the plasma and extravascular compartments are well understood, the mechanism underlying its antiatherogenic properties shall remain a mystery. Furthermore, because HDL are formed and degraded by complex mechanisms involving turnover of constituent elements, an understanding of these processes is also necessary as background to a discussion of degradation of this species.


High Density Lipoprotein Cholesterol Ester High Density Lipoprotein Cholesterol Efflux Plasma High Density Lipoprotein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    G.J. Miller and N.F. Miller, Plasma high density lipoproteins concentration and development of ischemic heart disease, Lancet. 1:16–20 (1975).PubMedCrossRefGoogle Scholar
  2. 2.
    Gordon, T., Castelli, W.P., Hjortland, M.C., Kamel, W.B., and Dawber, T.R., High density lipoprotein as a protective factor against coronary heart disease: The Framingham Study, Am. J. Med. 62:707–730 (1977).PubMedCrossRefGoogle Scholar
  3. 3.
    S. Eisenberg, High density lipoprotein metabolism, J. Lipid Res. 25:1017–1058 (1984).PubMedGoogle Scholar
  4. 4.
    R.L. Hamilton, M.C. Williams, C.J. Fielding, and R.J. Hajel, Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver, J. Clin. Invest. 58:667–680 (1976).PubMedCrossRefGoogle Scholar
  5. 5.
    P.H.R. Green, A.R. Tall, and R.M. Glickman, Rat intestine secretes discoidal high density lipoprotein, J. Clin. Invest. 61:528–534 (1978).PubMedCrossRefGoogle Scholar
  6. 6.
    T.G. Redgrave, and D.M. Small. Quantitation of the transfer of surface phospholipid of chylomicrons to the high density lipoprotein fraction during the catabolism of chylomicrons in the rat, J. Clin. Invest. 64:162–171 (1979).PubMedCrossRefGoogle Scholar
  7. 7.
    K. Shirai, R.L. Barnhart, R.L. Jackson, Hydrolysis of human plasma high density lipoprotein 2, phospholipids and triglycerides by hepatic lipase, Biochem. Biophys. Res. Commun. 100:591–599 (1981).PubMedCrossRefGoogle Scholar
  8. 8.
    P.J. Nestel, M. Reardon, and T. Billington, In vivo transfer of cholesteryl esters from high density lipoproteins to very low density Lipoproteins in Man, Biochim. Biophys. Acta. 573:403-407.Google Scholar
  9. 9.
    A. Sniderman, B. Teng, C. Vezina, and Y.L. Marcel, Cholesterol ester exchange between human plasma high and low density lipoproteins mediated by a plasma protein factor, Atherosclerosis. 31:327–333 (1978).PubMedCrossRefGoogle Scholar
  10. 10.
    C.C. Schwartz, M. Beiman, Z.R. Ulahcevic, and L. Swell, Multicompartmental analysis of cholesterol metabolism in man, J.Clin. Invest. 70:376–863 (1982).Google Scholar
  11. 11.
    M.C. Phillips, L.R. McLean, G.W. Stoudt and G.H. Rothblat, Mechanism of cholesterol efflux from cells, Atherosclerosis. 36:409 (1980).CrossRefGoogle Scholar
  12. 12.
    P. Julien, B. Fong, and A. Angel, Cardiac and peripheral lymph lipoproteins in dogs fed cholesterol and saturated fat, Arteriosclerosis. 4:435 (1984).PubMedCrossRefGoogle Scholar
  13. 13.
    R.C. Pittman and D. Steinberg, Sites and mechanisms of uptake and degradation of high density and low density lipoproteins, J. LipidRes. 25:1577–1585 (1984).PubMedGoogle Scholar
  14. 14.
    C. Glass, R.C. Pittman, M. Civen, and D. Steinberg, Uptake of high density lipoprotein associated Apoprotein A-I and cholesterol esters by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro, J. Biol. Chem. 260:744–750 (1985).PubMedGoogle Scholar
  15. 15.
    E. Reaven, Y.I. Chen, M. Spicher, and S. Azhar, Morphological evidence that high density lipoproteins are not internalized by steroid-producing cells during in situ organ perfusion, J. Clin. Invest. 1384-1397 (1984).Google Scholar
  16. 16.
    J.L. Goldstein, and M.S. Brown, The low-density lipoprotein pathway and its relation to atherosclerosis, Ann. Rev. Biochern. 46:897–930 (1977).CrossRefGoogle Scholar
  17. 17.
    G. Ponsin, J.T. Sparrow, A.M. Gotto Jr., and H.J. Pownall, In vivo interaction of synthetic acetylated apopeptides with high density lipoproteins in rat, J. Clin. Invest. 77:559–567 (1986).PubMedCrossRefGoogle Scholar
  18. 18.
    P.S. Roheim, D. Rachmilewitz, O. Stein, and Y. Stein, Metabolism of iodinated high density lipoproteins in the rat. I. Half-life in the circulation and uptake by organs, Biochim. Biophys. Acta 248:315–329 (1971).PubMedCrossRefGoogle Scholar
  19. 19.
    Rachmilewitz, D., O. Stein, P.S. Roheim, and Y. Stein, Metabolism of iodinated high density lipoproteins in the rat. II. Autoradiographic localization in the liver, Biochim. Biophys. Acta 270:414–425 (1972).PubMedCrossRefGoogle Scholar
  20. 20.
    G.A. Drevon, T. Berg, and K.R. Norum, Uptake and degradation of cholesterol ester labelled rat plasma lipoproteins in purified rat hepatocytes and non parenchymal liver cells, Biochem Biophys Acta, 487:122–136 (1977).PubMedCrossRefGoogle Scholar
  21. 21.
    P.S. Bachorik, F.A. Franklin, D.G. Virgil, and P.O. Kwiterovich Jr., High-affinity uptake and degradation of apolipoprotein E free high density lipoprotein and low density lipoprotein in cultured porcine hepatocytes, Biochemistry. 21:5675–5684 (1982).PubMedCrossRefGoogle Scholar
  22. 22.
    J.T. Gwynne, and B. Hess, The role of high density lipoproteins in rat adrenal cholesterol metabolism and steroidogenesis, J. Biol. Chem. 255:10833–10875 (1980).Google Scholar
  23. 23.
    N. Suzuki, N. Fidge, P. Nestel, and J. Yin, Interaction of serum lipoproteins with the intestine. Evidence for specific high density lipoproteins binding sites on isolated rat intestinal mucusal cells, J. Lipid Res. 24:253–264 (1983).PubMedGoogle Scholar
  24. 24.
    A. Angel, M.A. D’Costa, R. Yuen, Low density lipoprotein binding, internalization, and degradation in human adipose cells, Can. J.Biochem. 57:578–587 (1979).PubMedCrossRefGoogle Scholar
  25. 25.
    W. Stoffel, Transport and processing of apolipoproteins of high density lipoproteins, J. of Lipid Res. 25:1586–1592 (1984).Google Scholar
  26. 26.
    A. Scanu, R.E. Byrne, and C. Edelstein, Proteolytic events affecting plasma apolipoproteins at the co-and post-translational levels and after maturation, J. Lipid Res. 25:1593–1602 (1984).PubMedGoogle Scholar
  27. 27.
    H.R. Lijnen, and D. Collen, Degradation of the apoprotein A-l polypeptide chain of human high density lipoprotein by human plasmin, Thromb. Res. 24:151–156, (1981).PubMedCrossRefGoogle Scholar
  28. 28.
    D. Polacek, R.E. Byrne, G.M. Fless, and A.M. Scanu, In vitro proteolysis of human plasma low density lipoproteins by an elastase released from human blood polymorphonuclear cells, J. Biol. Chem. 261:2057 (1986).PubMedGoogle Scholar
  29. 29.
    W.A. Bradley, E.B. Gillian, A.M. Gotto Jr., and S.H. Gianturco, Apolipoprotein E degradation in human very low density lipoproteins by plasma protease(s): Chemical and biological consequences, Biochem. Biophys. Res. Commun. 109:1360–1367 (1982).PubMedCrossRefGoogle Scholar
  30. 30.
    M. Yamamoto, S. Ranganathn, and B.A. Kottke, Structure and Function of Human Low Density Lipoproteins, J. Biol. Chem. 8509-8513 (1985).Google Scholar
  31. 31.
    U.P. Steinbricher, J.L. Witztum, Y.A. Kesaniemi, and R. Elam, Comparison of glucosylated low density lipoprotein with methylated or cyclohexanedione treated low density lipoprotein in the measurement of receptor independent low density lipoprotein catabolism, J. Clin. Invest. 71:960–964 (1983).CrossRefGoogle Scholar
  32. 32.
    E.A. Brinton, J.F. Oram, C.H. Chen, J.J. Albers, and E.L. Bierman, Binding of high density lipoprotein to cultured fibroblasts after chemical alteration of apoprotein amino acid residues, J. Biol. Chem. 261:495–503 (1986).PubMedGoogle Scholar
  33. 33.
    U.P. Steinbrecher, S. Parthasarathy, D.S. Leake, J.L. Witztum, and D. Steinberg, Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids, Proc. Nat l Acad. Sci U.S.A. 81:3883–3887 (1984).CrossRefGoogle Scholar
  34. 34.
    T.L. Raymond, and S.A. Reynolds, Lipoprotein of the extravascular space: Alterations in low density lipoproteins of interstitial inflammatory fluid, J. Lipid Res. 24:113 (1983).PubMedGoogle Scholar
  35. 35.
    T.H. Avlinskas, D.R. van der Westhuyzen, E.L. Bierman, W. Gevers and G.A. Coetzee. Retro-endocytosis of low density lipoproteins by cultured bovine aortic smooth muscle cells, Biochim. Biophys. Acta 664:255–265 (1981).CrossRefGoogle Scholar
  36. 36.
    K. Tanaka, T. Nakamura, and A. Ichihara, A unique trypsin-like protease associated with plasma membranes of rat liver, J. Biol. Chem. 261, 2610–2615, (1986).PubMedGoogle Scholar
  37. 37.
    B.S. Fong, P.O. Rodrigues, and A. Angel, Characterization of low density lipoprotein binding of human adipocytes and adipocyte membranes, J. Biol. Chem. 259:10168–10174 (1984).PubMedGoogle Scholar
  38. 38.
    B. Fong, P.O. Rodrigues, A.M. Salter, B.P. Yip, J.P. Despres, R.E. Gregg, and A. Angel, J. Clin. Invest.75:1804–1812 (1985).PubMedCrossRefGoogle Scholar
  39. 39.
    A. Salter, B. Fong, J. Jimenez, and A. Angel, Involvement of apolipoprotein A-l in binding of high density lipoprotein to adipocyte plasma membranes. Arteriosclerosis 4:539A, (1984).Google Scholar
  40. 40.
    A. Angel, S. Thanabalasingham, D. Reichl, J.J. Pflug, G.R. Thompson, N.B. Myant, Effects of Starvation and plasma exchange on lecithin:cholesterol acyl transferase activity and cholesterol efflux and cholesterol fed pigs, Res. Exp. Med. 184:231–242 (1984).CrossRefGoogle Scholar
  41. 41.
    E.J. Schaefer, R. Wood, M. Kibata, L. Bjornson, and P.H. Schreibman, Mobilization of triglyceride but not cholesterol or tocopherol from human adipocytes during weight reduction, Am. J. Clin. Nutrition 37:749–754 (1983).Google Scholar
  42. 42.
    A. Angel, and G.A. Bray, Synthesis of fatty acids and cholesterol by liver, adipose tissue, and intestinal mucosa from obese and control patients, Eur. J. Clin. Invest. 355-362 (1979).Google Scholar

Copyright information

© Springer Science+Business Media New York 1986

Authors and Affiliations

  • A. Angel
    • 1
  • B. Fong
    • 1
  1. 1.Department of Medicine and Institute of Medical ScienceUniversity of Toronto and Division of Endocrinology and Metabolism, Toronto General HospitalTorontoCanada

Personalised recommendations